Elekta’s operations in Italy under investigation for suspected antitrust violations

STOCKHOLM, November 12, 2015 – Italian authorities have today initiated an
investigation into some employees of Elekta’s Italian operations for suspected
antitrust violations.
Elekta General Counsel, Jonas Bolander, said: “Elekta has very clear policies
and procedures regarding code of conduct and fair competition. Elekta has zero
tolerance toward any deviation of its code of conduct, of which fair competition
is one important element.”

Elekta is fully cooperating with the Italian authorities.

In fiscal year 2014/15 Italy accounted for 3.5 percent of Elekta’s total net
sales.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail:
 (gert.vansanten@elekta.com)gert.vansanten@elekta.com
Time zone: CET: Central European Time

Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 17:45 CET on November 12, 2015.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.